Eurand Announces Conference Call on Third Quarter 2010 Financial Results

AMSTERDAM, THE NETHERLANDS--(Marketwire - October 21, 2010) - Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, will host a conference call on Friday, November 5, 2010 at 8:30 a.m. ET to discuss its third quarter 2010 financial results. The conference call will be hosted by Gearóid Faherty, Chairman and Chief Executive Officer, and Mario Crovetto, Chief Financial Officer.

The conference call schedule is as follows:

7:00 a.m. ET: Release of third quarter 2010 financial results 8:20 a.m. ET: Dial in to participate in the conference call: -- U.S. Participants dial 1-877-407-9039 -- International Participants dial +1-201-689-8470 8:30 a.m. ET: Conference call begins Call Replay: A replay of the call will be available from 11:30 a.m. ET on November 5, 2010 through December 5, 2010. The Conference ID Number is 358370. -- U.S. Participants dial +1-877-870-5176 -- International Participants dial +1-858-384-5517 

Webcast: A live webcast of the call also will be available from the Investor Relations section of the corporate web site at www.eurand.com. Following the live webcast, the archived version of the call will be available at the same URL until December 5, 2010.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit www.eurand.com.